IGT-001

N/A

Report date: 2025/01/26 18:42:07

Base Information

Drug NameIGT-001
Drug Alias Nameengineered stem cell therapy (hydrogel) (InGel Therapeutics/Schepens Eye Research Institute)IGT-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Retinal stem cell therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInGel Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInGel Therapeutics IncSchepens Eye Research Institute Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A